A new mechanism has recently been identified in prostate cancer, a mechanism in whichcomplete loss of PTEN in combination with wild-typeTP53 surprisingly induced a strong cellular senescence response,which resulted in the inhibition of malignant cell growth. This evidence concerns the gene PTEN and prostate cancer.